Umeclidinium bromide/vilanterol
From Infogalactic: the planetary knowledge core
Umeclidinium bromide (TOP), vilanterol (BOTTOM)
|
|
| Combination of | |
|---|---|
| Umeclidinium bromide | Muscarinic antagonist |
| Vilanterol | Ultra-long-acting β2 agonist |
| Clinical data | |
| Trade names | Anoro Ellipta |
| AHFS/Drugs.com | entry |
| Pregnancy category |
|
| Legal status |
|
| Routes of administration |
Inhalation (DPI) |
| Identifiers | |
| ATC code | R03AL03 (WHO) |
Umeclidinium bromide/vilanterol (trade name Anoro Ellipta) is a combination drug approved for the treatment of chronic obstructive pulmonary disease (COPD).[1][2] It is applied as an inhalation.
References
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Drugs that are a combination of chemicals
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Combination drugs
- Drugs acting on the respiratory system
- Long-acting beta2-adrenergic agonists
- Respiratory system drug stubs
